Alexander S. Christensen

Gentofte, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study.

Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study.

Journal: Clinical and translational gastroenterology

Published: January 29, 2021

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).

Journal: Diabetes care

Published: February 28, 2020

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers.

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers.

Journal: Diabetes

Published: January 20, 2020

Effect of High Versus Low Carbohydrate Intake in the Morning on Glycemic Variability and Glycemic Control Measured by Continuous Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus-A Randomized Crossover Study.

Effect of High Versus Low Carbohydrate Intake in the Morning on Glycemic Variability and Glycemic Control Measured by Continuous Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus-A Randomized Crossover Study.

Journal: Nutrients

Published: December 27, 2019

Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes

Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes

Journal: Ugeskrift for laeger

Published: April 02, 2019

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD.

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD.

Journal: Frontiers in endocrinology

Published: June 19, 2018

Diagnosis and treatment of maturity onset diabetes of the young type 3

Diagnosis and treatment of maturity onset diabetes of the young type 3

Journal: Ugeskrift for laeger

Published: February 13, 2018

Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms.

Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms.

Journal: Leukemia research

Published: November 21, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026